查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1945428

2026年全球體外診斷設備市場報告

In-Vitro Diagnostics Instruments Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，體外診斷設備市場成長顯著，預計將以10.0%的複合年成長率從2025年的610.9億美元成長到2026年的671.8億美元。過去幾年的成長可歸因於慢性病盛行率上升、醫院檢查室基礎設施擴建、診斷劑技術進步、早期疾病檢測意識提升以及政府醫療保健政策等因素。

預計未來幾年體外診斷市場將快速成長，到2030年市場規模將達到994.4億美元，複合年成長率（CAGR）為10.3%。預測期內的成長要素包括分子診斷技術的進步、個人化醫療的擴展、人工智慧在診斷領域的應用、新興市場醫療保健的擴張以及對家用診斷設備的需求。預測期內的主要趨勢包括就地檢驗的普及、個人化診斷的推廣、快速分子檢測的廣泛應用、遠端患者監護的整合以及小型化檢測設備的出現。

慢性病和文明病的日益普遍預計將在未來幾年推動體外診斷市場的成長。慢性病和文明病是指主要受日常習慣、行為和環境因素影響的長期健康狀況（例如心臟病、糖尿病、肥胖症和某些癌症）。由於久坐不動的生活方式和不健康的飲食習慣，這些疾病的發生率正在上升。隨著慢性病和文明病的日益普遍，企業致力於應用早期檢測和監測工具來改善疾病管理，這推動了對體外診斷的需求不斷成長。例如，根據總部位於美國的非營利中間偏右智庫「美國行動論壇」（American Action Forum）稱，截至2024年，慢性病已成為美國一項重大的公共衛生問題，約60%的成年人患有至少一種慢性病，40%的成年人患有多種慢性病，預計到2050年，這一患病率將幾乎加倍。此外，慢性病治療市場預計將從2025年的97.4億美元成長到2034年的約380.2億美元。因此，慢性病和文明病的日益增加正在推動體外診斷設備市場的成長。

體外診斷市場的主要企業正致力於開發先進技術，例如數位聚合酵素鏈鎖反應(dPCR) 系統，以實現高精度、高靈敏度的核酸定量，從而推動下一代診斷的發展。數位聚合酵素鏈鎖反應(dPCR) 系統是一種先進的診斷設備，它透過將樣本分成數千個獨立的反應來定量 DNA 或 RNA 分子，從而實現卓越的檢測準確性和靈敏度。例如，總部位於荷蘭的生物技術公司 QIAGEN NV 於 2024 年 9 月推出了 QIAcuityDx 數位 PCR 系統，將其 dPCR 產品組合擴展到臨床診斷領域，主要專注於腫瘤檢測。這款完全整合、自動化的系統專為臨床應用而設計，其基於試劑盒的工作流程最大限度地減少了人工操作。 QIAcuityDx 配備了自動化分析和報告軟體，能夠快速且準確地檢測用於癌症診斷和治療監測的遺傳生物標記物，在確保結果可靠且可重複的同時，減少操作人員的參與。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球體外診斷設備市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 人工智慧（AI）和自主人工智慧
    • 生物技術、基因組學和精準醫學
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 物聯網、智慧基礎設施和互聯生態系統
  • 主要趨勢
    • 擴大即時檢測範圍
    • 個性化診斷
    • 擴大快速分子檢測的應用
    • 遠端患者監護整合
    • 小型化實驗室設備

第5章 終端用戶產業市場分析

  • 醫院
  • 診斷檢查室
  • 學術和研究機構
  • 血庫
  • 製藥和生物技術公司

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球體外診斷設備市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 全球體外診斷設備市場規模、對比及成長率分析
  • 全球體外診斷設備市場表現：規模與成長，2020-2025年
  • 全球體外診斷設備市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場總量（TAM）

第9章 市場細分

  • 依產品類型
  • 臨床化學、免疫檢測、分子診斷、血液學、微生物學、凝血、其他產品類型
  • 透過使用
  • 感染疾病、癌症、心臟病學、腎臟病學、自體免疫疾病及其他應用領域
  • 最終用戶
  • 醫院和診斷檢查室、學術研究機構、照護現場、血庫、製藥和生物技術公司以及其他醫療機構
  • 按類型細分：臨床化學
  • 全自動臨床化學分析儀、半全自動臨床化學分析儀、照護現場臨床化學分析儀
  • 按類型細分：免疫檢測
  • 酵素免疫分析法（ELISA）系統、化學冷光免疫檢測（CLIA）分析儀、免疫檢測（RIA）系統
  • 按類型細分：分子診斷
  • 聚合酵素鏈鎖反應（PCR）系統、次世代定序（NGS）平台、去氧核糖核酸微陣列、等溫擴增裝置
  • 按類型細分：血液學
  • 自動血液分析儀、手動血液分析儀、止血分析儀、凝血分析儀
  • 按類型細分：微生物學
  • 微生物鑑定系統、抗菌藥物敏感性試驗（AST）系統、血液培養系統、自動化微生物分析儀
  • 按類型細分：凝血
  • 凝血測量設備、血小板功能分析儀、血栓彈性圖（TEG）系統、照護現場凝血測量設備
  • 按類型細分：其他產品類型
  • 照護現場診斷設備和其他檢測設備

第10章 區域與國家分析

  • 全球體外診斷設備市場：區域分析、預測與趨勢，2020-2025年、2025-2030年預測、2035年預測
  • 全球體外診斷設備市場：國家、績效及預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 體外診斷設備市場：競爭格局及市場佔有率（2024年）
  • 體外診斷設備市場：公司估值矩陣
  • 體外診斷設備市場：公司概況
    • F. Hoffmann-La Roche Ltd
    • Danaher Corporation
    • Abbott Laboratories
    • Thermo Fisher Scientific
    • Siemens Healthineers AG

第37章：其他領先和創新企業

  • Becton Dickinson and Company, Sysmex Corporation, Bio-Rad Laboratories Inc, Agilent Technologies, Hologic Inc, Qiagen NV, Illumina Inc, Ortho Clinical Diagnostics, Beckman Coulter Inc, Mindray Medical International Limited, Horiba Ltd, Randox Laboratories Ltd, DiaSorin SpA, Werfen SA, Trinity Biotech plc

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年體外診斷設備市場：提供新機會的國家
  • 2030年體外診斷設備市場：充滿新機會的細分市場
  • 2030年體外診斷設備市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME3MIVDI04_G26Q1

In-vitro diagnostic instruments are medical devices used to analyze biological samples, such as blood, urine, or tissue, outside the human body. Their primary function is to detect, diagnose, monitor, and manage diseases or medical conditions by providing accurate and timely laboratory test results. These instruments aid clinical decision-making and support personalized patient care.

The primary product types of in-vitro diagnostic instruments include clinical chemistry, immunoassay, molecular diagnostics, hematology, microbiology, coagulation, and others. Clinical chemistry instruments are digital tools, often leveraging AI, to analyze blood, urine, and other body fluids, helping identify biochemical abnormalities, improve diagnostic accuracy, and guide treatment planning. These instruments are applied across multiple areas, including infectious diseases, cancer, cardiology, nephrology, and autoimmune disorders. They serve a diverse range of end users, including hospitals, diagnostic laboratories, academic and research institutes, point-of-care facilities, blood banks, and pharmaceutical and biotechnology companies.

Tariffs are impacting the in-vitro diagnostics instruments market by increasing costs of imported reagents, analyzers, and precision components, particularly affecting molecular diagnostics and clinical chemistry segments. Asia-Pacific manufacturing hubs such as China and India are most impacted, causing supply chain disruptions and higher device prices. However, tariffs are encouraging local manufacturing investments, which could improve domestic production capabilities and reduce long-term dependency on imports.

The in-vitro diagnostics instruments market research report is one of a series of new reports from The Business Research Company that provides in-vitro diagnostics instruments market statistics, including in-vitro diagnostics instruments industry global market size, regional shares, competitors with a in-vitro diagnostics instruments market share, detailed in-vitro diagnostics instruments market segments, market trends and opportunities, and any further data you may need to thrive in the in-vitro diagnostics instruments industry. This in-vitro diagnostics instruments market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The in-vitro diagnostics instruments market size has grown strongly in recent years. It will grow from $61.09 billion in 2025 to $67.18 billion in 2026 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, increasing hospital lab infrastructure, advances in diagnostic reagents, growing awareness for early disease detection, government healthcare initiatives.

The in-vitro diagnostics instruments market size is expected to see rapid growth in the next few years. It will grow to $99.44 billion in 2030 at a compound annual growth rate (CAGR) of 10.3%. The growth in the forecast period can be attributed to technological advancements in molecular diagnostics, growth of personalized medicine, integration of AI in diagnostics, expansion of emerging markets healthcare, demand for home-based diagnostic devices. Major trends in the forecast period include point-of-care testing expansion, personalized diagnostics, rapid molecular testing adoption, remote patient monitoring integration, miniaturized lab instruments.

The rising prevalence of chronic and lifestyle related diseases is expected to enhance the growth of the in vitro diagnostics instruments market in the coming years. Chronic and lifestyle related diseases refer to long term health conditions primarily influenced by daily habits, behaviors, and environmental factors, such as heart disease, diabetes, obesity, and certain cancers. The incidence of these diseases is increasing due to sedentary lifestyles and unhealthy dietary habits. In vitro diagnostics instruments are experiencing higher demand as the growing burden of chronic and lifestyle related diseases encourages companies to adopt early detection and monitoring tools for improved disease management. For example, in 2024, according to the American Action Forum, a U.S. based non profit, center right think tank, chronic diseases remain a major public health concern in the United States, with nearly 60 percent of adults living with at least one condition, 40 percent managing multiple conditions, and prevalence expected to nearly double by 2050. Furthermore, the chronic disease treatment market is projected to reach approximately 38.02 billion dollars by 2034, up from 9.74 billion dollars in 2025. Therefore, the rising prevalence of chronic and lifestyle related diseases is enhancing the growth of the in vitro diagnostics instruments market.

Prominent companies operating in the in-vitro diagnostics instruments market are focusing on developing advanced technologies, such as digital polymerase chain reaction (dPCR) systems, to achieve highly precise and sensitive nucleic acid quantification for next-generation diagnostics. Digital polymerase chain reaction (dPCR) systems are sophisticated diagnostic instruments that quantify DNA or RNA molecules by dividing samples into thousands of individual reactions, allowing for exceptional accuracy and sensitivity in detection. For example, in September 2024, QIAGEN N.V., a Netherlands-based biotechnology company, introduced the QIAcuityDx Digital PCR System, expanding its dPCR portfolio into clinical diagnostics with a primary focus on oncology testing. This fully integrated and automated system is specifically designed for clinical use, featuring a cartridge-based workflow that minimizes manual handling. Equipped with automated analysis and reporting software, the QIAcuityDx enables rapid and precise detection of genetic biomarkers for cancer diagnosis and therapy monitoring, reducing operator involvement while ensuring reliable and reproducible results.

In January 2025, Fremman Ltd., a UK-based investment company, acquired a majority stake in DIESSE Diagnostica Senese S.p.A. for an undisclosed amount. Through this acquisition, Fremman Ltd aims to expand DIESSE Diagnostica Senese's international presence, strengthen its leadership in specialty in vitro diagnostics, and support ongoing innovation to advance global diagnostic capabilities and improve patient outcomes. DIESSE Diagnostica Senese S.p.A. is an Italy-based medical equipment company that provides in vitro diagnostic instruments.

Major companies operating in the in-vitro diagnostics instruments market are F. Hoffmann-La Roche Ltd, Danaher Corporation, Abbott Laboratories, Thermo Fisher Scientific, Siemens Healthineers AG, Becton Dickinson and Company, Sysmex Corporation, Bio-Rad Laboratories Inc, Agilent Technologies, Hologic Inc, Qiagen N.V., Illumina Inc, Ortho Clinical Diagnostics, Beckman Coulter Inc, Mindray Medical International Limited, Horiba Ltd, Randox Laboratories Ltd, DiaSorin S.p.A., Werfen S.A., Trinity Biotech plc

North America was the largest region in the in-vitro diagnostics instruments market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the in-vitro diagnostics instruments market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the in-vitro diagnostics instruments market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The in-vitro diagnostics instruments market consists of sales of point-of-care testing devices, flow cytometry instruments, histopathology and cytology instruments, and molecular point-of-care systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

In-Vitro Diagnostics Instruments Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses in-vitro diagnostics instruments market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for in-vitro diagnostics instruments ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The in-vitro diagnostics instruments market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Clinical Chemistry; Immunoassay; Molecular Diagnostics; Hematology; Microbiology; Coagulation; Other Product Types
  • 2) By Application: Infectious Diseases; Cancer; Cardiology; Nephrology; Autoimmune Diseases; Other Applications
  • 3) By End User: Hospitals And Diagnostic Laboratories; Academic And Research Institutes; Point-Of-Care Settings; Blood Banks; Pharmaceutical And Biotechnology Companies; Other Healthcare Facilities
  • Subsegments:
  • 1) By Clinical Chemistry: Automated Clinical Chemistry Analyzers; Semi-Automated Clinical Chemistry Analyzers; Point-Of-Care Clinical Chemistry Devices
  • 2) By Immunoassay: Enzyme-Linked Immunosorbent Assay (ELISA) Systems; Chemiluminescence Immunoassay (CLIA) Analyzers; Radioimmunoassay (RIA) Systems
  • 3) By Molecular Diagnostics: Polymerase Chain Reaction (PCR) Systems; Next-Generation Sequencing (NGS) Platforms; Deoxyribonucleic Acid Microarrays; Isothermal Amplification Devices
  • 4) By Hematology: Automated Hematology Analyzers; Manual Hematology Analyzers; Hemostasis Analyzers; Coagulation Analyzers
  • 5) By Microbiology: Microbial Identification Systems; Antibiotic Susceptibility Testing (AST) Systems; Blood Culture Systems; Automated Microbial Analyzers.
  • 6) By Coagulation: Coagulometers; Platelet Function Analyzers; Thromboelastography (TEG) Systems; Point-Of-Care Coagulation Devices
  • 7) By Other Product Types: Point-Of-Care Diagnostic Devices; Miscellaneous Laboratory Instruments
  • Companies Mentioned: F. Hoffmann-La Roche Ltd; Danaher Corporation; Abbott Laboratories; Thermo Fisher Scientific; Siemens Healthineers AG; Becton Dickinson and Company; Sysmex Corporation; Bio-Rad Laboratories Inc; Agilent Technologies; Hologic Inc; Qiagen N.V.; Illumina Inc; Ortho Clinical Diagnostics; Beckman Coulter Inc; Mindray Medical International Limited; Horiba Ltd; Randox Laboratories Ltd; DiaSorin S.p.A.; Werfen S.A.; Trinity Biotech plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. In-Vitro Diagnostics Instruments Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global In-Vitro Diagnostics Instruments Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. In-Vitro Diagnostics Instruments Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global In-Vitro Diagnostics Instruments Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Biotechnology, Genomics & Precision Medicine
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Point-Of-Care Testing Expansion
    • 4.2.2 Personalized Diagnostics
    • 4.2.3 Rapid Molecular Testing Adoption
    • 4.2.4 Remote Patient Monitoring Integration
    • 4.2.5 Miniaturized Lab Instruments

5. In-Vitro Diagnostics Instruments Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Diagnostic Laboratories
  • 5.3 Academic & Research Institutes
  • 5.4 Blood Banks
  • 5.5 Pharmaceutical & Biotechnology Companies

6. In-Vitro Diagnostics Instruments Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global In-Vitro Diagnostics Instruments Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global In-Vitro Diagnostics Instruments PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global In-Vitro Diagnostics Instruments Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global In-Vitro Diagnostics Instruments Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global In-Vitro Diagnostics Instruments Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global In-Vitro Diagnostics Instruments Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. In-Vitro Diagnostics Instruments Market Segmentation

  • 9.1. Global In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Clinical Chemistry, Immunoassay, Molecular Diagnostics, Hematology, Microbiology, Coagulation, Other Product Types
  • 9.2. Global In-Vitro Diagnostics Instruments Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Infectious Diseases, Cancer, Cardiology, Nephrology, Autoimmune Diseases, Other Applications
  • 9.3. Global In-Vitro Diagnostics Instruments Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Diagnostic Laboratories, Academic And Research Institutes, Point-Of-Care Settings, Blood Banks, Pharmaceutical And Biotechnology Companies, Other Healthcare Facilities
  • 9.4. Global In-Vitro Diagnostics Instruments Market, Sub-Segmentation Of Clinical Chemistry, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Automated Clinical Chemistry Analyzers, Semi-Automated Clinical Chemistry Analyzers, Point-Of-Care Clinical Chemistry Devices
  • 9.5. Global In-Vitro Diagnostics Instruments Market, Sub-Segmentation Of Immunoassay, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Enzyme-Linked Immunosorbent Assay (ELISA) Systems, Chemiluminescence Immunoassay (CLIA) Analyzers, Radioimmunoassay (RIA) Systems
  • 9.6. Global In-Vitro Diagnostics Instruments Market, Sub-Segmentation Of Molecular Diagnostics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymerase Chain Reaction (PCR) Systems, Next-Generation Sequencing (NGS) Platforms, Deoxyribonucleic Acid Microarrays, Isothermal Amplification Devices
  • 9.7. Global In-Vitro Diagnostics Instruments Market, Sub-Segmentation Of Hematology, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Automated Hematology Analyzers, Manual Hematology Analyzers, Hemostasis Analyzers, Coagulation Analyzers
  • 9.8. Global In-Vitro Diagnostics Instruments Market, Sub-Segmentation Of Microbiology, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Microbial Identification Systems, Antibiotic Susceptibility Testing (AST) Systems, Blood Culture Systems, Automated Microbial Analyzers
  • 9.9. Global In-Vitro Diagnostics Instruments Market, Sub-Segmentation Of Coagulation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Coagulometers, Platelet Function Analyzers, Thromboelastography (TEG) Systems, Point-Of-Care Coagulation Devices
  • 9.10. Global In-Vitro Diagnostics Instruments Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Point-Of-Care Diagnostic Devices, Miscellaneous Laboratory Instruments

10. In-Vitro Diagnostics Instruments Market Regional And Country Analysis

  • 10.1. Global In-Vitro Diagnostics Instruments Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global In-Vitro Diagnostics Instruments Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific In-Vitro Diagnostics Instruments Market

  • 11.1. Asia-Pacific In-Vitro Diagnostics Instruments Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China In-Vitro Diagnostics Instruments Market

  • 12.1. China In-Vitro Diagnostics Instruments Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India In-Vitro Diagnostics Instruments Market

  • 13.1. India In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan In-Vitro Diagnostics Instruments Market

  • 14.1. Japan In-Vitro Diagnostics Instruments Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia In-Vitro Diagnostics Instruments Market

  • 15.1. Australia In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia In-Vitro Diagnostics Instruments Market

  • 16.1. Indonesia In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea In-Vitro Diagnostics Instruments Market

  • 17.1. South Korea In-Vitro Diagnostics Instruments Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan In-Vitro Diagnostics Instruments Market

  • 18.1. Taiwan In-Vitro Diagnostics Instruments Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia In-Vitro Diagnostics Instruments Market

  • 19.1. South East Asia In-Vitro Diagnostics Instruments Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe In-Vitro Diagnostics Instruments Market

  • 20.1. Western Europe In-Vitro Diagnostics Instruments Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK In-Vitro Diagnostics Instruments Market

  • 21.1. UK In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany In-Vitro Diagnostics Instruments Market

  • 22.1. Germany In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France In-Vitro Diagnostics Instruments Market

  • 23.1. France In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy In-Vitro Diagnostics Instruments Market

  • 24.1. Italy In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain In-Vitro Diagnostics Instruments Market

  • 25.1. Spain In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe In-Vitro Diagnostics Instruments Market

  • 26.1. Eastern Europe In-Vitro Diagnostics Instruments Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia In-Vitro Diagnostics Instruments Market

  • 27.1. Russia In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America In-Vitro Diagnostics Instruments Market

  • 28.1. North America In-Vitro Diagnostics Instruments Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA In-Vitro Diagnostics Instruments Market

  • 29.1. USA In-Vitro Diagnostics Instruments Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada In-Vitro Diagnostics Instruments Market

  • 30.1. Canada In-Vitro Diagnostics Instruments Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America In-Vitro Diagnostics Instruments Market

  • 31.1. South America In-Vitro Diagnostics Instruments Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil In-Vitro Diagnostics Instruments Market

  • 32.1. Brazil In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East In-Vitro Diagnostics Instruments Market

  • 33.1. Middle East In-Vitro Diagnostics Instruments Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa In-Vitro Diagnostics Instruments Market

  • 34.1. Africa In-Vitro Diagnostics Instruments Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa In-Vitro Diagnostics Instruments Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. In-Vitro Diagnostics Instruments Market Regulatory and Investment Landscape

36. In-Vitro Diagnostics Instruments Market Competitive Landscape And Company Profiles

  • 36.1. In-Vitro Diagnostics Instruments Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. In-Vitro Diagnostics Instruments Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. In-Vitro Diagnostics Instruments Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

37. In-Vitro Diagnostics Instruments Market Other Major And Innovative Companies

  • Becton Dickinson and Company, Sysmex Corporation, Bio-Rad Laboratories Inc, Agilent Technologies, Hologic Inc, Qiagen N.V., Illumina Inc, Ortho Clinical Diagnostics, Beckman Coulter Inc, Mindray Medical International Limited, Horiba Ltd, Randox Laboratories Ltd, DiaSorin S.p.A., Werfen S.A., Trinity Biotech plc

38. Global In-Vitro Diagnostics Instruments Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The In-Vitro Diagnostics Instruments Market

40. In-Vitro Diagnostics Instruments Market High Potential Countries, Segments and Strategies

  • 40.1 In-Vitro Diagnostics Instruments Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 In-Vitro Diagnostics Instruments Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 In-Vitro Diagnostics Instruments Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer